Evidence map›Paper›PMID 38799309›Full record

ArticleACS omega2024

Influence of Solvents and Halogenation on ESIPT of Benzimidazole Derivatives for Designing Turn-on Fluorescence Probes.

Murillo H Queiroz, Tiago V Alves, Roberto Rivelino, Sylvio Canuto

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Murillo H QueirozDepartamento de Físico-Química, Instituto de Química, Universidade Federal da Bahia, Rua Barão de Jeremoabo, 147, Salvador, Bahia 40170-115, Brazil.ORCID https://orcid.org/0000-0003-0956-7903
Tiago V AlvesDepartamento de Físico-Química, Instituto de Química, Universidade Federal da Bahia, Rua Barão de Jeremoabo, 147, Salvador, Bahia 40170-115, Brazil.ORCID https://orcid.org/0000-0001-9129-3272
Roberto RivelinoInstituto de Física, Universidade Federal da Bahia, Salvador, Bahia 40210-340, Brazil.ORCID https://orcid.org/0000-0003-2679-1640
Sylvio CanutoInstituto de Física, Universidade de São Paulo, CP 66318, São Paulo, São Paulo 05315-970, Brazil.ORCID https://orcid.org/0000-0002-9942-8714

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work reports a theoretical investigation of the solvent polarity as well as the halogenation of benzimidazole derivatives during excited state intramolecular proton transfer (ESIPT). It details how the environment and halogen substitution may contribute to the efficiency of ESIPT upon keto-enol tautomerism and exploits this effect to design fluorescence sensing. For this purpose, we first examine the conformational equilibrium of benzimidazole derivatives containing different halogen atoms, which results in intramolecular proton transfer, using density-functional theory (DFT) combined with the polarizable continuum model (PCM). Then we evaluate the fluorescence of the benzimidazole derivatives in different dielectric constants within time-dependent DFT (TD-DFT) approaches. Our results quantitatively allow the determination of large Stokes shifts in nonpolar solvents around 100 nm. These theoretical results are in agreement with experimental solvatochromism studies of benzimidazoles. The effect of halogenation, with fluorine, chlorine, and bromine, is less important than solvent polarization when ESIPT takes place. Thus, halogenation can be properly chosen depending on the interest of the synthesis of benzimidazole-based turn-on fluorescence in appropriate solvents.

Identifiers

PMID38799309
PMCPMC11112562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.